Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Cattran

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 1, 1986
Plasmapheresis and antiplatelet agents in the treatment of the hemolytic uremic syndrome secondary to mitomycinS Chow, J Roscoe, D C Cattran
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 1, 1994
Long-term benefits of angiotensin-converting enzyme inhibitor therapy in patients with severe immunoglobulin a nephropathy: a comparison to patients receiving treatment with other antihypertensive agents and to patients receiving no therapyD C Cattran, C Greenwood, S Ritchie
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1992
Predicting progression in membranous glomerulonephritisD C Cattran, Y Pei, C Greenwood
Kidney International|January 20, 1999
Impact of gender on the renal response to angiotensin IIJ A Miller, L A Anacta, D C Cattran
Nephron|January 1, 1983
Anemia of chronic renal failure: inhibition of erythropoiesis by uremic serumM H Freedman, D C Cattran, E F Saunders
Metabolism: Clinical and Experimental|November 1, 1975
Inhibition of lipoprotein lipase by uremic plasma, a possible cause of hypertriglyceridemiaT Murase, D C Cattran, B Rubenstein, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 29, 2001
Predicting progression in IgA nephropathyL P Bartosik, G Lajoie, L Sugar, et al.
Clinical Nephrology|April 1, 1980
Dialysis hyperlipemia: response to dietary manipulationsD C Cattran, G Steiner, S S Fenton, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1974
Hypertriglyceridemia in uremia and the use of triglyceride turnover to define pathogenesisD C Cattran, G Steiner, S S Fenton, et al.
Annals of Internal Medicine|October 1, 1979
Hyperlipidemia after renal transplantation: natural history and pathophysiologyD C Cattran, G Steiner, D R Wilson, et al.
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 1, 1986
Plasmapheresis and antiplatelet agents in the treatment of the hemolytic uremic syndrome secondary to mitomycinS Chow, J Roscoe, D C Cattran
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 1, 1994
Long-term benefits of angiotensin-converting enzyme inhibitor therapy in patients with severe immunoglobulin a nephropathy: a comparison to patients receiving treatment with other antihypertensive agents and to patients receiving no therapyD C Cattran, C Greenwood, S Ritchie
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1992
Predicting progression in membranous glomerulonephritisD C Cattran, Y Pei, C Greenwood
Kidney International|January 20, 1999
Impact of gender on the renal response to angiotensin IIJ A Miller, L A Anacta, D C Cattran
Nephron|January 1, 1983
Anemia of chronic renal failure: inhibition of erythropoiesis by uremic serumM H Freedman, D C Cattran, E F Saunders
Metabolism: Clinical and Experimental|November 1, 1975
Inhibition of lipoprotein lipase by uremic plasma, a possible cause of hypertriglyceridemiaT Murase, D C Cattran, B Rubenstein, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 29, 2001
Predicting progression in IgA nephropathyL P Bartosik, G Lajoie, L Sugar, et al.
Clinical Nephrology|April 1, 1980
Dialysis hyperlipemia: response to dietary manipulationsD C Cattran, G Steiner, S S Fenton, et al.
Transactions - American Society for Artificial Internal Organs|January 1, 1974
Hypertriglyceridemia in uremia and the use of triglyceride turnover to define pathogenesisD C Cattran, G Steiner, S S Fenton, et al.
Annals of Internal Medicine|October 1, 1979
Hyperlipidemia after renal transplantation: natural history and pathophysiologyD C Cattran, G Steiner, D R Wilson, et al.
Pageof 7